LumiraDx Investor Presentation Deck slide image

LumiraDx Investor Presentation Deck

Current POC Solutions Have Major Limitations The traditional approach to POC test development has limited scalability and has resulted in ineffective, inefficient and costly solutions X Poor clinical performance in areas of high clinical need X High cost of total ownership X Limited test menu lumiraDx™ Coagulation Respiratory Molecular Copyright © 2022 LuminaDx Lit. All Rights Reserved. Worldwide. Respiratory Immunoassay Diabetes, Cardiovascular Diabetes, Inflammation Cardiac, Blood gas, Metabolic
View entire presentation